Neuphoria Therapeutics Inc. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-10-18: Form 20-F; Period of report 2023-06-30; Description 20-F; Document bnox-20230630.htm.
- 2022-10-14: Form 20-F; Period of report 2022-06-30; Description 20-F; Document bnox-20220630.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-10-18 | 20-F | 2023-06-30 | 20-F | bnox-20230630.htm |
| 2022-10-14 | 20-F | 2022-06-30 | 20-F | bnox-20220630.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |